News
RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...
A Walmart, a restaurant, a grocery store and more are among the locations where potential exposures to a measles case in ...
Value in Health, the official journal of ISPOR-The Professional Society for Health Economics and Outcomes Research, announced today the publication of a special themed section of research papers that ...
Food and Drug Administration Commissioner Marty Makary said at a news conference that the agency would take steps to eliminate the synthetic dyes by the end of 2026.
Barclays analyst Luke Sergott maintained a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target of $185.00.
Evercore ISI analyst Elizabeth Anderson CFA maintained a Hold rating on Quest Diagnostics (DGX – Research Report) yesterday and set a price ...
UC Davis Health is unveiling two brand-new initiatives -- the Health Venture Studio and the Investing in the Future of ...
3d
Zacks Investment Research on MSNHologic vs. MYGN: Which Molecular Diagnostics Player Has More Upside?In recent times, investors have been increasingly drawn to companies operating in the molecular diagnostics space, a rapidly growing segment within the broader in-vitro diagnostics (IVD) market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results